The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation

泛素在氯化钠协同转运蛋白调节中的作用

基本信息

  • 批准号:
    8308546
  • 负责人:
  • 金额:
    $ 13.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-10 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hypertension represents a major public health concern. To date, each form of inherited hypertension has been linked to defective salt handling in the kidney. This application seeks to explore the mechanisms involved in the regulation of one of the key salt-handling transporters in the kidney, the sodium chloride co- transporter (NCC) located in distal convoluted tubule. Previous studies have reported decreased NCC activity in response to the presence of WNK4 (a kinase associated with a form of genetic hypertension called Gordon's Syndrome) and phorbol esters (chemical analogs of diacylglycerol, a common pathway for hormonal stimulation) but the mechanism by which NCC activity is reduced is unclear. This application will seek to demonstrate that WNK4 and phorbol esters decrease NCC activity by decreasing the amount of NCC expressed at the cell surface, a process that occurs by enhancing the ubiquitination of NCC, thereby promoting degradation of the co-transporter. The experimental model will be a cell model utilizing an immortalized mouse distal convoluted tubule cell line with native NCC activity and intact regulatory pathways. The association between activity, surface expression, and ubiquitination will be established by measuring NCC activity via radiotracer uptake, NCC cell surface expression via biotinylation and immunofluorescence, and ubiquitination via immunoprecipitation and immunoblotting in cells gene-silenced for WNK4 or treated with phorbol esters. The mechanisms of NCC ubiquitination will also be determined, including sites of ubiquitination and required enzymes. This project will help train Dr. Benjamin Ko as a physician-scientist and facilitate his transition to an independent investigator and contributing member of the scientific community. Public Health Relevance Hypertension represents a tremendous public health concern with staggering morbidity and mortality. As inherited hypertension is intimately tied to sodium reabsorption and many of our treatments for hypertension inhibit NCC activity, understanding the regulation of NCC activity will give us insight into the pathogenesis of hypertension and may one day provide further treatment avenues to control hypertension.
描述(由申请人提供): 高血压是一个主要的公共卫生问题。迄今为止,每种遗传性高血压都与肾脏中盐处理缺陷有关。本申请试图探索参与调节肾脏中的关键盐处理转运蛋白之一,位于远曲小管中的氯化钠协同转运蛋白(NCC)的机制。先前的研究已经报道了NCC活性降低,以响应WNK 4(一种与称为戈登综合征的遗传性高血压形式相关的激酶)和佛波酯(二酰基甘油的化学类似物,激素刺激的常见途径)的存在,但NCC活性降低的机制尚不清楚。本申请将试图证明WNK 4和佛波醇酯通过减少在细胞表面表达的NCC的量来降低NCC活性,该过程通过增强NCC的泛素化而发生,从而促进共转运蛋白的降解。实验模型将是利用具有天然NCC活性和完整调控途径的永生化小鼠远曲小管细胞系的细胞模型。通过放射性示踪剂摄取测量NCC活性,通过生物素化和免疫荧光测量NCC细胞表面表达,以及通过免疫沉淀和免疫印迹在WNK 4基因沉默或用佛波醇酯处理的细胞中测量泛素化,将建立活性、表面表达和泛素化之间的关联。NCC泛素化的机制也将被确定,包括泛素化的位点和所需的酶。这个项目将有助于培养本杰明高博士作为一个医生,科学家,并促进他过渡到一个独立的研究者和科学界的贡献成员。高血压是一个巨大的公共卫生问题,发病率和死亡率惊人。由于遗传性高血压与钠重吸收密切相关,并且我们的许多高血压治疗方法都抑制NCC活性,因此了解NCC活性的调节将使我们深入了解高血压的发病机制,并有一天可能提供进一步的治疗途径来控制高血压。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanisms of angiotensin II stimulation of NCC are time-dependent in mDCT15 cells.
在 mDCT15 细胞中,血管紧张素 II 刺激 NCC 的机制具有时间依赖性。
A role for the circadian clock protein Per1 in the regulation of the NaCl co-transporter (NCC) and the with-no-lysine kinase (WNK) cascade in mouse distal convoluted tubule cells.
生物钟蛋白 Per1 在调节小鼠远曲小管细胞中 NaCl 协同转运蛋白 (NCC) 和无赖氨酸激酶 (WNK) 级联中的作用。
  • DOI:
    10.1074/jbc.m113.531095
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richards,Jacob;Ko,Benjamin;All,Sean;Cheng,Kit-Yan;Hoover,RobertS;Gumz,MichelleL
  • 通讯作者:
    Gumz,MichelleL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin S Ko其他文献

Benjamin S Ko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin S Ko', 18)}}的其他基金

The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation
泛素在氯化钠协同转运蛋白调节中的作用
  • 批准号:
    8031665
  • 财政年份:
    2010
  • 资助金额:
    $ 13.09万
  • 项目类别:
The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation
泛素在氯化钠协同转运蛋白调节中的作用
  • 批准号:
    7905878
  • 财政年份:
    2008
  • 资助金额:
    $ 13.09万
  • 项目类别:
The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation
泛素在氯化钠协同转运蛋白调节中的作用
  • 批准号:
    8125100
  • 财政年份:
    2008
  • 资助金额:
    $ 13.09万
  • 项目类别:
The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation
泛素在氯化钠协同转运蛋白调节中的作用
  • 批准号:
    7513206
  • 财政年份:
    2008
  • 资助金额:
    $ 13.09万
  • 项目类别:
The Role of Ubiquitin in Sodium Chloride Co-Transporter Regulation
泛素在氯化钠协同转运蛋白调节中的作用
  • 批准号:
    7668437
  • 财政年份:
    2008
  • 资助金额:
    $ 13.09万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.09万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了